Emcure Pharma acquires Canadian co & its unit Marcan
Emcure Pharmaceuticals, a India (Pune)-based drug maker, has acquired Canada’s International Pharmaceutical Generics Ltd. and its marketing arm Marcan Pharmaceuticals in a... Read More
US FDA approves Impax’s Emverm chewable tablets to treat pinworm
Impax Laboratories, Inc., a specialty pharmaceutical company, announced that the United States Food and Drug Administration (FDA) has approved the company’s supplemental... Read More
Xbrane Signs Deal With Helvetic BioPharma for its Lead Ranibizumab Biosimilar, Xlucane
Posted on18 Jan 2016
TagsBiosimilar of Novartis' eye drug Lucentis launched in India, biosimilar version of Lucentis, biotech companies in the Middle East, Lucentis, Ranibizumab, Ranibizumab biosimilar, Xbrane, Xbrane Signs Deal With Helvetic BioPharma for its Lead Ranibizumab Biosimilar, Xlucane
Comments0
Xbrane Biopharma, a commercial phase biopharmaceutical company specialized in High Demand Complex Generics, announced that the company has signed a sales and... Read More
Fuji Pharma buys darbepoetin alfa from Chong Kun Dang Pharmaceutical
Japanese pharma company Fuji Pharma recently in licensed darbepoetin alfa, a bone marrow stimulant, from Chong Kun Dang Pharmaceutical, a Seoul-based company,... Read More
BENEPALI®, the First Etanercept Biosimilar Referencing Enbrel®, Approved in the European Union
The joint venture between Biogen and Samsung BioLogics, Samsung Bioepis, has been granted European Commission (EC) approval for BENEPALI® , an etanercept... Read More
Highlights of Shire – Baxalta Deal
Posted on18 Jan 2016
Comments0
Shire acquires drug maker Baxalta on recently announced deal valued at about $32 billion. The combination would create a giant in the treatment... Read More
Torrent launched biosimilar for Adalimumab, under brand name Adfrar
Posted on12 Jan 2016
TagsAdalimumab, Adfrar, Exemptia, Toritz, Torrent launched biosimilar for Adalimumab, torrent pharma, under brand name Adfrar
Comments0
Ahmedabad-based drug major Torrent Pharmaceuticals launched its biosimilar for Adalimumab, a therapy for the treatment of auto immune disorders like rheumatoid arthritis... Read More
Merck Acquires IOmet Pharma
Merck, known as MSD outside the United States and Canada, announced today that it has acquired IOmet, a privately-held UK-based drug discovery... Read More
2015 Merger-Acquisition in Global Pharmaceutical Industry
Posted on11 Jan 2016
Comments0
2015 Merger – Acquisition in Pharma Company Takeover candidate Deal Value $ Completed 3SBio (China) Zhejiang Wansheng Pharma (China) $85.0 million Jul-15... Read More
US FDA accepts Sanofi and Regeneron’s sarilumab BLA for review
Posted on11 Jan 2016
Comments0
Sanofi, a global healthcare leader, and Regeneron Pharmaceuticals, Inc., a leading science-based biopharmaceutical company, announced that the US Food and Drug Administration... Read More